In particular, upregulation of PDLIM1 inhibits HCC metastasis through activating Hippo signaling and loss of PDLIM1 confers poor prognosis, suggesting that PDLIM1 could be a potential biomarker for metastatic HCC9. Here, PDLIM1 is linked to hepatocellular carcinoma.